Nerlynx® (neratinib)
for Breast Cancer

Nerlynx (neratinib) is a targeted therapy used to treat HER2-positive breast cancer. It is prescribed alone or with other medications for early-stage breast cancer and for advanced or metastatic cases. Nerlynx works by interfering with HER2, a protein that promotes cancer cell growth, helping to slow or stop the spread of cancer.

Heart
Other top medicines used to treat Breast Cancer